Cercar
01/02/2023
Pathophysiology of Chronic Bronchial Infection in Bronchiectasis
Solarat, B, Perea, L, Faner, R, de la Rosa, D, Martinez-Garcia, MA, Sibila, O. Pathophysiology of Chronic Bronchial Infection in Bronchiectasis. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(2)DOI:10.1016/j.arbres.2022.09.004. PMID:36180278. IF:8.700(Q1/1D).
01/01/2023
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Crespo-Lessmann A., Curto E., Medina, EFM, Palones E., Soler A.B., Maza S.S., Soto-Retes L., Plaza V.. Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S389402. PMID:36699564. IF:3.700(Q1/3D).
01/01/2023
Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
Molina J., Plaza V., Nuevo J., Gutiérrez M., Sicras-Mainar A., Valero A.. Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100232. PMID:37496866. IF:(Q/D).
01/01/2023
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
Plaza V., Cañete C., Domingo C., Martínez Rivera C., Muñoz X.. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2022.100231. PMID:37496871. IF:(Q/D).
01/01/2023
Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
Barroso B., Valverde-Monge M., Alobid I., Olaguibel J.M., Rial M.J., Quirce S., Arismendi E., Barranco P., Betancor D., Bobolea I., Cárdaba B., Cruz Carmona M.J., Curto E., Domínguez-Ortega J., González-Barcala F.J., Martínez-Rivera C., Mahíllo-Fernández I., Muñoz X., Picado C., Plaza V., Rodrigo Muñoz J.M., Soto-Retes L., Valero A., Del Pozo V., Mullol J., Sastre J.. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0812. PMID:35416154. IF:6.700(Q1/2D).
01/01/2023
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Pérez de Llano L., Cisneros C., Domínguez-Ortega J., Martínez-Moragón E., Olaguibel J.M., Plaza V., Quirce S., Dávila I.. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0857. PMID:36040046. IF:6.700(Q1/2D).
01/01/2023
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids
Gil-Martínez M., Lorente-Sorolla C., Rodrigo-Muñoz J.M., Lendínez M.Á., Núñez-Moreno G., de la Fuente L., Mínguez P., Mahíllo-Fernández I., Sastre J., Valverde-Monge M., Quirce S., Caballero M.L., González-Barcala F.J., Arismendi E., Bobolea I., Valero A., Muñoz X., Cruz M.J., Martínez-Rivera C., Plaza V., Olaguibel J.M., del Pozo V.. Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(2)DOI:10.3390/ijms24021611. PMID:36675122. IF:4.900(Q1/3D).
01/01/2023
Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(1)DOI:10.1016/j.arbres.2022.07.011. PMID:35970652. IF:8.700(Q1/1D).